ATG4B Stable Knockout HeLa Cell Line
| Unit |
1×10⁶ cells / 1.0 ml |
|---|---|
| Cell Type |
Stable (KO/Expressing) Cells |
| Tissue Type |
Cervix |
| Organism |
Human (H. sapiens) |
| Donor History | |
| Growth Properties |
Adherent ,epithelial-like |
| Growth Conditions |
PriCoat™ T25 Flasks (G299) or Applied Cell Extracellular Matrix (G422) are recommended for optimal cell culture. Dulbecco's Modified Eagle Medium (DMEM) ,High Glucose (TM500) + 10% FBS + 2 mM L-Glutamine (G275) + 1 mM Sodium Pyruvate (TM057) + 1% Penicillin/Streptomycin Solution (G255) ,37.0°C ,5% CO₂. |
| Immortalization Method | |
| Full Information |
The ATG4B Stable Knockout HeLa Cell Line was developed using CRISPR-Cas9 technology to specifically disrupt the ATG4B gene, a key cysteine protease involved in autophagy, particularly in the lipidation and processing of LC3 and GABA type A receptor-associated protein (GABARAP) family proteins. This cell line exhibits a severe but incomplete defect in autophagy, characterized by an impaired ability to lipidate LC3B, resulting in a significant reduction in autophagosome formation and cargo degradation. However, residual lipidation of GABARAPL1 and GABARAPL2 can still occur due to the compensatory activity of other ATG4 isoforms. This unique cell line is invaluable for research focused on dissecting the specific roles of ATG4B in autophagy and its contribution to cellular processes such as protein aggregation, intracellular trafficking, and degradation.Complete list of cell lines from this panel:Cat. T3588 – ATG4B Stable Knockout HeLa Cell LineCat. T3589 – ATG4A/B Stable Double Knockout HeLa Cell LineCat. T3590 – ATG4A/B/C Stable Triple Knockout HeLa Cell Line
Mikrobiologické aplikace
NGS
Rapid testy
PCR plasty
Třepačky
Suché lázně
Fluorometry
Buněčné kultury
PCR, qPCR, RT
Detekce Mycoplasmat
Reverzní transkripce
Alergie
Intolerance
Elisa
Imunologické analyzátory
Veterinární imunologie
Alergie u zvířat
Intolerance u zvířat
Biochemie
Imunoanalýza
